AVIR icon

Atea Pharmaceuticals

118 hedge funds and large institutions have $171M invested in Atea Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 44 increasing their positions, 41 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
-14
Holders Change %
-10.61%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
44
Reduced
41
Closed
20
Calls
$260K
Puts
$78K
Net Calls
+$182K
Net Calls Change
+$88K
Name Holding Trade Value Shares
Change
Shares
Change %
Marshall Wace
126
Marshall Wace
United Kingdom
-$126K -33,674 Closed
YIH
127
Y-Intercept (HK)
Hong Kong
-$108K -28,882 Closed
GCM
128
Graham Capital Management
Connecticut
-$37.8K -10,113 Closed
Allspring Global Investments
129
Allspring Global Investments
North Carolina
-$7.15K -1,911 Closed
FIA
130
FNY Investment Advisers
New York
-$5K -1,521 Closed
US Bancorp
131
US Bancorp
Minnesota
-$3.8K -1,015 Closed
FHA
132
First Horizon Advisors
Tennessee
-$3.74K -1,000 Closed
RTL
133
Red Tortoise LLC
Georgia
-$1.59K -426 Closed
LC
134
Lindbrook Capital
California
-$1.41K -378 Closed
ODG
135
O'Dell Group
Ohio
-$748 -200 Closed
Point72 Asset Management
136
Point72 Asset Management
Connecticut
-$34 -9 Closed
NC
137
NewSquare Capital
Pennsylvania
-$30 -8 Closed